Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes.

Rosalie A Scholtes, Anne C Hesp, Charlotte M Mosterd, Frank Geurts, Ewout J Hoorn, Daan J Touw, Merle M Krebber, Jaap A Joles, Hiddo J L Heerspink, Daniël H van Raalte

Journal: Circulation 2022;146(24):1895-1897

PMID: 36508495

Abstract

Address: Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, the Netherlands (R.A.S., A.C.H., C.M.M., D.H.v.R.).; Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, the Netherlands (F.G., E.J.H.).; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands (D.J.T., H.J.L.H.).; Department of Nephrology and Hypertension, University Medical Center, Utrecht, the Netherlands (M.M.K., J.A.J.).
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.